Advanced search
Publication Cover
Baylor University Medical Center Proceedings
The peer-reviewed journal of Baylor Scott & White Health
Volume 33, 2020 - Issue 3
Submit an article Journal homepage
11
Views
1
CrossRef citations to date
0
Altmetric
Miscellany

Gadolinium-induced Kounis syndrome including electrocardiographic considerations

Nicholas G. KounisDepartment of Cardiology, University of Patras Medical School, Patras, Greece; Correspondence[email protected])
, MD, PhD,
Ioanna KoniariElectrophysiology and Device Department, University Hospital of South Manchester NHS Foundation Trust, Manchester, UK;
, MD, PhD,
Grigorios TsigkasDepartment of Cardiology, University of Patras Medical School, Patras, Greece;
, MD, PhD,
George D. SoufrasDepartment of Cardiology, “Saint Andrews” State General Hospital, Patras, Greece
, MD, PhD,
Panagiotis PlotasDepartment of Cardiology, University of Patras Medical School, Patras, Greece;
, MD, PhD,
Periklis DavlourosDepartment of Cardiology, University of Patras Medical School, Patras, Greece;
, MD, PhD &
George HahalisDepartment of Cardiology, University of Patras Medical School, Patras, Greece;
, MD, PhD show all
Pages 474-476 | Received 02 Apr 2020, Accepted 30 Apr 2020, Published online: 06 Jul 2020

  • Kirchin MA, Pirovano G, Venetianer C, Spinazzi A. Safety assessment of gadobenate dimeglumine (MultiHance): extended clinical experience from phase I studies to post-marketing surveillance. J Magn Reson Imaging. 2001;14(3):281–294. doi:10.1002/jmri.1184.
  • Abusnina W, Shehata M, Abouzid M, Price M, Zeid F. Kounis syndrome secondary to gadolinium contrast agent. Proc (Bayl Univ Med Cent). 2019;32(2):253–255. doi:10.1080/08998280.2019.1581319.
  • Raisch DW, Garg V, Arabyat R, et al. Anaphylaxis associated with gadolinium-based contrast agents: data from the Food and Drug Administration's Adverse Event Reporting System and review of case reports in the literature. Expert Opin Drug Saf. 2014;13(1):15–23. doi:10.1517/14740338.2013.832752.
  • Franckenberg S, Berger F, Schaerli S, Ampanozi G, Thali M. Fatal anaphylactic reaction to intravenous gadobutrol, a gadolinium-based MRI contrast agent. Radiol Case Rep. 2018;13(1):299–301. doi:10.1016/j.radcr.2017.09.012.
  • Biagioni E, Coloretti I, Disalvo F, et al. Case report of a patient who survived after cardiac arrest and cardiogenic shock by anaphylactic reaction to gadolinium during magnetic resonance imaging. Radiol Case Rep. 2020;15(3):266–268. doi:10.1016/j.radcr.2019.12.006.
  • Yoshida T, Sumi C, Uba T, Miyata H, Umegaki T, Kamibayashi T. A rare case of atropine-resistant bradycardia following sugammadex administration. JA Clin Rep. 2020;6(1):18. doi:10.1186/s40981-020-00326-7.
  • Cayla G, Silvain J, Collet JP, Montalescot G. Updates and current recommendations for the management of patients with non-ST-elevation acute coronary syndromes: what it means for clinical practice. Am J Cardiol. 2015;115(5 Suppl):10A–22A. doi:10.1016/j.amjcard.2015.01.003.
  • Kosuge M, Uchida K, Imoto K, et al. Prognostic value of ST-segment elevation in lead aVR in patients with type A acute aortic dissection. J Am Coll Cardiol. 2015;65(23):2570–2571. doi:10.1016/j.jacc.2015.02.075.
  • Tanaka H, Urushima M, Hirano S, Takenaga M. An acute adverse reaction with ST elevation induced by magnetic resonance contrast media: Kounis syndrome. Intern Med. 2019;58(2):243–245. doi:10.2169/internalmedicine.0802-18.
  • Demoulin R, Poyet R, Capilla E, et al. Infarctus du myocarde inférieur compliqué de bloc auriculo-ventriculaire complet et d’arrêt cardiocirculatoire dans les suites d’une injection de gadolinium: à propos d’une observation de syndrome de Kounis [Inferior myocardial infarction complicated by complete heart block and cardiac arrest following a gadolinium injection: A case of Kounis syndrome]. Ann Cardiol Angeiol (Paris). 2017;66(5):319–322. doi:10.1016/j.ancard.2017.09.015.
  • Memon S, Chhabra L, Masrur S, Parker MW. Allergic acute coronary syndrome (Kounis syndrome). Proc (Bayl Univ Med Cent). 2015;28(3):358–362. doi:10.1080/08998280.2015.11929274.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.